Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1551

URSODIOL
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

Basic Information

ChEMBL ID CHEMBL1551
Name URSODIOL
Phase Approved
Structure Type MOL
InChI Key RUDATBOHQWOJDD-UZVSRGJWSA-N
Therapeutic ✓ Yes

Known Names

Acide ursodeoxycholique Acido ursodeoxicolico Actigall Cholurso Destolit NSC-683769 Urdox Urso Urso 250 Urso forte Ursodeoxycholate Ursodeoxycholic acid +5 more
7
Targets
17
Activities
3
Assay Types
5
PK Parameters
20
Publications
17
Known Names
20
Indications
1
Mechanisms

Molecular Properties

392.6
MW (Da)
4.48
ALogP
3
HBA
3
HBD
77.8
PSA (Ų)
0.66
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1987
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral

Flags

Natural Product
USAN Year 1988

Extended Properties

Molecular Formula C24H40O4
MW 392.58
Aromatic Rings 0
Heavy Atoms 28
NP-Likeness 2.43

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Bile acid receptor FXR agonist AGONIST Bile acid receptor

Indications

Liver Cirrhosis, Biliary Liver Cirrhosis, Biliary Cholelithiasis Cholestasis, Intrahepatic Diabetes Mellitus, Type 2 Diabetes, Gestational Hepatitis C, Chronic Liver Diseases Liver Diseases Adenomatous Polyposis Coli Arthritis, Rheumatoid Chemical and Drug Induced Liver Injury Cholangitis, Sclerosing Cholestasis Colorectal Neoplasms Diabetes Mellitus Heart Failure Hepatitis D Inflammation Jaundice, Obstructive

ATC Classification

A05AA02
ursodeoxycholic acid
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: BILE AND LIVER THERAPY

Activity Summary

EC50 10 meas. best 5.62
IC50 4 meas. best 5.58
Ki 3 meas. best 5.95

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
CDGSH iron-sulfur domain-containing protein 1
CHEMBL1795168
Ki 5.95 5.95 1134.0 1
G-protein coupled bile acid receptor 1
CHEMBL5409
EC50 5.62 5.03 2390.0 2
Aminopeptidase N
CHEMBL4117
IC50 5.58 5.58 2600.0 1
Unchecked
CHEMBL612545
EC50 5.49 4.67 3270.0 7
Hepatic sodium/bile acid cotransporter
CHEMBL5287
IC50 5.44 5.44 3600.0 1
Autotaxin
CHEMBL3691
IC50 5.03 5.03 9260.0 1
CDGSH iron-sulfur domain-containing protein 1
CHEMBL1795168
IC50 4.58 4.58 26540.0 1
Ileal sodium/bile acid cotransporter
CHEMBL2778
Ki 4.12 4.12 75000.0 1

Pharmacokinetic Data

Parameter Value Units Species
T1/2 2.0 hr Homo sapiens
Tmax 1.0 hr Rattus norvegicus
Tmax 0.75 hr Rattus norvegicus
Tmax 0.75 hr Rattus norvegicus
Tmax 1.0 hr Rattus norvegicus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
CDGSH iron-sulfur domain-containing protein 1 Ki = 1134.0 nM 5.95 Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged M... 27687671
G-protein coupled bile acid receptor 1 EC50 = 2390.0 nM 5.62 Agonist activity at human GPBAR1 expressed in HEK293 cells assessed as increase ... 25735208
Aminopeptidase N IC50 = 2600.0 nM 5.58 PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopep... -
Unchecked EC50 = 3270.0 nM 5.49 Agonist activity at MRGPRX4 83S (unknown origin) expressed in CHO-K1 cells asses... 37967029
Hepatic sodium/bile acid cotransporter IC50 = 3600.0 nM 5.44 TP_TRANSPORTER: inhibition of Taurocholate uptake in NTCP-expressing HeLa cells 10565843
Unchecked EC50 = 4930.0 nM 5.31 Agonist activity at MRGPRX4 83L (unknown origin) expressed in HEK293 cells co-ex... 37967029
Autotaxin IC50 = 9260.0 nM 5.03 Inhibition of human ATX in using LPC as substrate by fluorescence based micropla... 38091892
CDGSH iron-sulfur domain-containing protein 1 IC50 = 26540.0 nM 4.58 Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged M... 27687671
Unchecked EC50 = 33800.0 nM 4.47 Agonist activity at MRGPRX4 83L (unknown origin) expressed in CHO cells assessed... 37967029
G-protein coupled bile acid receptor 1 EC50 = 36400.0 nM 4.44 Agonist activity at human TGR5 expressed in CHO cells by luciferase assay 18307294
Unchecked EC50 = 41100.0 nM 4.39 Agonist activity at MRGPRX4 83L (unknown origin) expressed in human 1321N1 gliob... 37967029
Unchecked EC50 = 41100.0 nM 4.39 Agonist activity at MRGPRX4 83L expressed in human HEK293 cells co- expressing G... 37975421
Unchecked EC50 = 47500.0 nM 4.32 Agonist activity at MRGPRX4 83S in human LN229 glioblastoma cells assessed as ch... 37967029
Unchecked EC50 = 47500.0 nM 4.32 Agonist activity at MRGPRX4 83S expressed in human HEK293 cells co- expressing G... 37975421
Ileal sodium/bile acid cotransporter Ki = 75000.0 nM 4.12 TP_TRANSPORTER: inhibition of Taurocholate uptake in ASBT-expressing COS cells 9458785

Literature References

Data from ChEMBL 36 via Core Engine